These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 6861127)

  • 1. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT; Dembs N
    Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I; Guttman P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):663-6. PubMed ID: 7107395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
    Wong KH; Zhang H; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1981 Jan; 43(1):93-9. PubMed ID: 7459244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
    Wong KH; Wallen CA; Wheeler KT
    J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y; Hoshino T; Barker M; Deen DF
    Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
    Taylor YC; Brown JM
    Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
    Wheeler KT; Wallen CA; Wolf KL; Siemann DW
    Br J Cancer; 1984 Jun; 49(6):787-93. PubMed ID: 6733024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
    Mulcahy RT
    Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hirst DG; Brown JM; Hazlehurst JL
    Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased therapeutic benefit through the addition of misonidazole to a nitrosourea-radiation combination.
    Siemann DW; Hill SA
    Cancer Res; 1986 Feb; 46(2):629-32. PubMed ID: 3940631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization by hypoxic pretreatment with misonidazole: an interaction of damage at the DNA level.
    Taylor YC; Evans JW; Brown JM
    Radiat Res; 1987 Mar; 109(3):364-73. PubMed ID: 3550868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.